Written and maintained by CASRAI Editorial Board
Last updated
Short answer
Just-in-time (JIT) inventory is a stocking strategy in which materials arrive in step with actual use instead of being held in large reserves. The U.S. EPA describes JIT delivery as coordinating material deliveries to better align with process consumption, so less is stored on site and suppliers deliver more often in smaller batches. In a lab or clinic, that means a supply is reordered because it was used, not because a shelf looked empty on a calendar date.
Ask CASRAI · free to try
Ask about this guide — your first 2 questions are free.
Suggested question: “What is just-in-time inventory in simple terms?”
Definition and scope
EPA’s Lean and Chemicals Toolkit defines just-in-time delivery as an inventory strategy implemented to reduce in-process inventory by coordinating material deliveries to better align with process consumption. Three ideas sit inside that definition:
- Less on-site stock. EPA notes that applying JIT to chemical management typically means fewer chemicals are stored on site.
- Smaller, more frequent deliveries. Suppliers deliver in smaller batches, more often.
- Use-triggered replenishment. EPA states that in a JIT system the need for a delivery is typically signaled by actual use of a material.
JIT comes from lean manufacturing. EPA’s guide for environmental professionals lists just-in-time production and jidoka (built-in quality) as the two pillars of the Toyota-style system, with standardization as the foundation, and describes the pull principle as letting customers pull value through the enterprise by producing to meet real demand. For a research lab, clinic or hospital supply room, the practical meaning is narrower: match what you hold to what you actually consume.
How it works in practice
The mechanism EPA describes has three parts, and each one is a design choice for the site that adopts it.
- A signal tied to consumption. Use of the material, not a fixed schedule, tells the supplier or the stores function that a delivery is needed. Signal methods such as two-bin systems are covered in our kanban inventory guide.
- Smaller lots, delivered more often. Each delivery is smaller than a bulk order, so more deliveries are received over the same period.
- Less storage space committed. Because less is held, less space and less held stock need to be managed on site.
EPA also states the cost tradeoff plainly: moving to JIT chemical deliveries can increase the per-unit cost of chemical purchases, yet many organizations find the total system cost advantages significant. The comparison therefore has to be made on total system cost, not on unit price alone.
Related concepts
JIT is often confused with the tools used to run it or the tools used to limit its risk. The table below separates them; each row points to the page that covers it.
| Concept | Relationship to JIT | Where to read more |
|---|---|---|
| Kanban inventory | A signal-based replenishment approach that can be used to trigger use-based reordering | Kanban inventory |
| Par level | A target stocking quantity; a different control from a pure use-signaled delivery | Par level inventory |
| Safety stock and buffer stock | Reserve held against supply or demand variation; the counterweight to a lean approach | Safety stock vs buffer stock |
| Bulk stocking | The opposite end of the spectrum: larger, less frequent purchases | JIT vs bulk stocking of medical consumables |
| Lean laboratory practice | The wider lean framework in which EPA lists JIT | Lean laboratory |
Where it matters for labs, clinics and supply decisions
Chemical inventories and expiry
EPA reports that some organizations found, before moving to JIT chemical deliveries, that as much as 40 percent of their chemical inventories were being sent to the hazardous waste stream without ever being used. That is EPA’s reported observation of some organizations, not a guaranteed result for any one lab. It does show why JIT is discussed alongside hazardous-materials storage and expiry: stock that is never used still has to be stored, tracked and eventually disposed of. EPA presents JIT as creating opportunities for reducing chemical risk and waste.
The resilience tradeoff
EPA’s material is about waste and cost. A second public source looks at the other side. A U.S. Department of Health and Human Services white paper on preventing drug shortages and supply chain vulnerabilities (prepared by the Office of the Secretary with ASPE, CMS, FDA and ASPR) states that mitigation and prevention tools, such as buffer inventory and capacity, are essential supply strategies. It also links mismatched incentives to inadequate inventory management practices that limit safety stocks and excess capacity that would enable a swift response to increased demand or decreased supply. The paper concerns drug supply chains and does not use the phrase just-in-time, so it is not a verdict on JIT. It is a reason to treat lean stock and reserve stock as a trade, not as a single right answer.
The same paper notes that CMS sought comment on separate Medicare payment to hospitals for maintaining a buffer stock of essential medicines (CY 2024 OPPS final rule, 88 FR 82127-30) and did not adopt a policy.
A question checklist for supply decisions
These are questions to put to each item category, drawn from the two sources above. They are prompts for a local decision, not instructions, and the answers depend on the site.
- Is there a clear use signal that tells the supplier or stores team when to replenish? (EPA: delivery is signaled by actual use.)
- Does the item expire, or is it a chemical that becomes waste if unused? (EPA’s chemical-inventory example.)
- Is the item one where a supply interruption would stop work, so that a reserve is worth holding? (HHS: buffer inventory is named as an essential supply tool.)
- Has total system cost, not only per-unit price, been compared? (EPA on per-unit cost versus system cost.)
Common misunderstandings
- JIT does not mean zero stock. EPA’s definition speaks of reducing inventory and fewer chemicals stored on site, not eliminating it.
- JIT is not the same as kanban. Kanban is one way to generate the use signal; JIT is the strategy of aligning deliveries to consumption. See kanban inventory.
- JIT is not NIH Just-in-Time. In grants administration, NIH uses “Just-in-Time” for a different purpose, the submission of certain application information after review. That is covered in our NIH just-in-time submission guide and has nothing to do with inventory.
- Lower per-unit price is not the test. EPA notes that JIT can raise the per-unit cost of purchases while the total system cost still favors it for many organizations.
FAQ
What is just-in-time inventory in simple terms?
It is a way of stocking in which supplies are delivered to match actual use, so less is held on site and deliveries are smaller and more frequent (EPA, Lean and Chemicals Toolkit, Chapter 4).
What triggers a delivery in a JIT system?
According to EPA, the need for a delivery is typically signaled by actual use of a material.
Is just-in-time inventory always cheaper?
No. EPA states that JIT chemical deliveries can increase the per-unit cost of purchases, and that many organizations find total system cost advantages significant. The answer depends on the whole system.
Does JIT conflict with holding buffer stock?
The two are different strategies and can be weighed against each other. HHS names buffer inventory as an essential supply strategy in its drug-shortage white paper, which concerns drug supply chains.
Sources
- U.S. EPA, Lean and Chemicals Toolkit, Chapter 4 (archived snapshot of 19 January 2025; page last updated 20 August 2024). Checked 30 October 2026.
- U.S. EPA, Environmental Professional’s Guide to Lean and Six Sigma, Chapter 2 (page updated 21 July 2026). Checked 30 October 2026.
- U.S. Department of Health and Human Services, Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States. Checked 30 October 2026.
